Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 31 Clinics in the Gundersen Health System health system


The results below represent the care of 3,309 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
Ashley Wellness Center

The number of patients or providers is too small for
purposes of reliably reporting performance
GNP Health and Wellness Center

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Calmar Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Decorah Clinic
N=186
98.39 %
View Historical Data
Gundersen - Galesville Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Harmony Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Houston Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - La Crescent Clinic
N=107
99.07 %
View Historical Data
Gundersen - La Crosse Clinic
N=1526
98.49 %
View Historical Data
Gundersen - Lansing Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Onalaska Clinic
N=895
97.99 %
View Historical Data
Gundersen - Ossian Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Prairie du Chien Clinic
N=131
98.47 %
View Historical Data
Gundersen - Sparta Clinic
N=150
96.67 %
View Historical Data
Gundersen - Spring Grove

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen - Tomah Clinic
N=167
99.40 %
View Historical Data
Gundersen - Viroqua Clinic
N=147
97.96 %
View Historical Data
Gundersen - Waukon Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen Boscobel Area - Boscobel Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen Boscobel Area - Fennimore Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Gundersen Boscobel Area - Muscoda Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
PLH Family Med Fayette

The number of patients or providers is too small for
purposes of reliably reporting performance
PLH Family Med Postville

The number of patients or providers is too small for
purposes of reliably reporting performance
PLH Family Med West Union

The number of patients or providers is too small for
purposes of reliably reporting performance
Riverside Corporate Wellness

The number of patients or providers is too small for
purposes of reliably reporting performance
STJ Family Med Elroy

The number of patients or providers is too small for
purposes of reliably reporting performance
STJ Family Med Hillsboro

The number of patients or providers is too small for
purposes of reliably reporting performance
STJ Family Med Wonewoc

The number of patients or providers is too small for
purposes of reliably reporting performance
TCM Family Med Blair

The number of patients or providers is too small for
purposes of reliably reporting performance
TCM Family Med Independence

The number of patients or providers is too small for
purposes of reliably reporting performance
TCM Family Med Whitehall

The number of patients or providers is too small for
purposes of reliably reporting performance

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.

Based on trials involving other secondary prevention therapies, the ACC and AHA recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions.

This measure shows the percentage of people 18 to 75 years of age with a diagnosis coronary or other atherosclerotic vascular disease who were prescribed oral antiplatelet therapy, unless contraindicated, in the measurement year.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.